The variability in comfortable effort level across experimental sessions as assessed by measures of speaking fundamental frequency (SFF) and vocal intensity (VI) has been reported for normal adult speakers. However, no such data are available for young children. The goal of this study was to determine the variability in SFF and VI seen in normally developing young children. Fifteen males and 14 females between the ages of 3 and 4 years were asked to repeat a vowel, a sentence, and four words at a comfortable speaking level on 3 separate days, each 1 week apart. SFF and VI were determined for each utterance. Statistical treatment of the data revealed that when combining all the data, there were no significant differences for mean SFF or VI across test sessions. However, the young females generally spoke with greater VI than young males. These results suggest that normal-speaking children at a very young age are, on the average, similar in the degree of variability to adults for SFF and VI across experimental sessions when asked to set their own level of output. These findings provide a baseline for the extent of variability in SFF and VI seen in normally developing young children.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.